help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on October 11, 2002, doi:10.1164/rccm.200204-363OC

Am. J. Respir. Crit. Care Med., Volume 166, Number 10, November 2002, 1375-1381

A more recent version of this article appeared on November 15, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200204-363OCv1
166/10/1375    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, I.
Right arrow Articles by Experimental ICU Study Group,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, I.
Right arrow Articles by Experimental ICU Study Group,

Submitted on April 24, 2002
Accepted on October 3, 2002

Lung Deposition and Efficiency of Nebulized Amikacin during E. coli Pneumonia in Ventilated Piglets

Ivan Goldstein1, Frederic Wallet2, Armelle Nicolas-Robin1, Fabio Ferrari1, Charles-Hugo Marquette3, Jean-Jacques Rouby1*, and Experimental ICU Study Group1

1 Department of Anesthesiology, La Pitie-Salpetriere Hospital, Paris, France, 2 Department of Bacteriology, La Pitie-Salpetriere Hospital, Paris, France, 3 DHURE and INSERM U 416, University of Medicine, Lille, France

* To whom correspondence should be addressed. E-mail: jjrouby.pitie{at}invivo.edu.

Lung tissue deposition and antibacterial efficiency of nebulized and intravenous amikacin (AMK) were compared in anesthetized and ventilated piglets suffering from a bronchopneumonia produced by the intrabronchial inoculation of Escherichia coli. AMK was administered 24 hrs following the inoculation, either through an ultrasonic nebulizer (45 mg/kg, n=10) or by intravenous infusion (15 mg/kg, n=8). Piglets were sacrificed 1 hour after a second AMK administration performed 24 hrs after the first one and lung tissue concentrations of AMK and lung bacterial burden were assessed on multiple lung specimens. The amount of nebulized AMK reaching the tracheobronchial tree represented 38 ± 6% of the initial nebulizer AMK charge. After nebulization, AMK lung tissue concentrations were 3 to 30 fold higher than after intravenous administration and were influenced by the severity of lung lesions : 188 ± 175 µg/g in lung segments with mild bronchopneumonia versus 40 ± 65 µg/g in lung segments with severe bronchopneumonia (p<0.01). Lung bacterial burden was significantly lower in the aerosol group than in the intravenous group (median = 0 cfu/g vs median = 5.102 cfu/g, p < 0.001). In conclusion, the deposition of AMK in infected lung parenchyma and the efficiency of bacterial killing were greater after nebulization than following intravenous administration.


Key words: aerosol,aminoglycosides,piglets,bronchopneumonia, mechanical ventilation




This article has been cited by other articles:


Home page
Eur Respir JHome page
O. Sibila, C. Agusti, A. Torres, S. Baquero, S. Gando, J. R. Patron, J. G. Morato, D. H. Goffredo, N. Bassi, and C. M. Luna
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Eur. Respir. J., December 1, 2007; 30(6): 1167 - 1172.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. R. Badia, D. Soy, M. Adrover, M. Ferrer, M. Sarasa, A. Alarcon, C. Codina, and A. Torres
Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients
J. Antimicrob. Chemother., August 1, 2004; 54(2): 508 - 514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 294 - 305.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society